MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers.
El Ayed M, Bonnel D, Longuespée R, Castelier C, Franck J, Vergara D, Desmons A, Tasiemski A, Kenani A, Vinatier D, Day R, Fournier I, Salzet M.
Med Sci Monit. 2010 Aug;16(8):BR233-45.
Follicular fluid.
Edwards RG.
J Reprod Fertil. 1974 Mar;37(1):189-219. doi: 10.1530/jrf.0.0370189.
Ovarian tumor antigens.
Bhattacharya M, Barlow JJ.
Cancer. 1978 Sep;42(3 Suppl):1616-20. doi: 10.1002/1097-0142(197809)42:3+<1616::aid-cncr2820420840>3.0.co;2-1.
[Inhibin].
Blanc MR.
Reprod Nutr Dev (1980). 1980;20(2):573-86.
A 2-D liquid separations/mass mapping method for interlysate comparison of ovarian cancers.
Kachman MT, Wang H, Schwartz DR, Cho KR, Lubman DM.
Anal Chem. 2002 Apr 15;74(8):1779-91. doi: 10.1021/ac011159c.
Identification of candidate biomarker mass (m/z) ranges in serous ovarian adenocarcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
Periyasamy A, Gopisetty G, Veluswami S, Joyimallaya Subramanium M, Thangarajan R.
Biomarkers. 2015;20(5):292-8. doi: 10.3109/1354750X.2015.1068862.
Classifications of ovarian cancer tissues by proteomic patterns.
Zhu Y, Wu R, Sangha N, Yoo C, Cho KR, Shedden KA, Katabuchi H, Lubman DM.
Proteomics. 2006 Nov;6(21):5846-56. doi: 10.1002/pmic.200600165.
O-Linked glycome and proteome of high-molecular-mass proteins in human ovarian cancer ascites: Identification of sulfation, disialic acid and O-linked fucose.
Karlsson NG, McGuckin MA.
Glycobiology. 2012 Jul;22(7):918-29. doi: 10.1093/glycob/cws060. Epub 2012 Mar 14.
Gender Differences in Low-Molecular-Mass-Induced Acute Lung Inflammation in Mice.
Xie Y, Xie D, Li B, Zhao H.
Int J Mol Sci. 2021 Jan 3;22(1):419. doi: 10.3390/ijms22010419.
Characterization of the Ovarian Tumor Peptidome.
Liu T, Rodland KD, Smith RD.
Vitam Horm. 2018;107:515-531. doi: 10.1016/bs.vh.2018.01.020. Epub 2018 Feb 22.
